Nalaganje...
Developing Outcomes Assessments as Endpoints for Registrational Clinical Trials of Antibacterial Drugs: 2015 Update From the Biomarkers Consortium of the Foundation for the National Institutes of Health
One important component in determining the benefits and harms of medical interventions is the use of well-defined and reliable outcome assessments as endpoints in clinical trials. Improving endpoints can better define patient benefits, allowing more accurate assessment of drug efficacy and more info...
Shranjeno v:
| izdano v: | Clin Infect Dis |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Oxford University Press
2016
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4741356/ https://ncbi.nlm.nih.gov/pubmed/26668337 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/civ927 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|